Back to Rare Disease

NCT01623076

NCT01623076
Active, Not Recruiting Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You must be 6 years old or older
  • Both males and females can participate
  • You (or your parent/guardian if you are a child) must be able to give your agreement to take part in the study
  • If you are between 10 and 17 years old, you must also be able to give your own agreement to participate
  • You must have been diagnosed with NMO (Neuromyelitis Optica), NMOSD (Neuromyelitis Optica Spectrum Disorder), TM (Transverse Myelitis), or ON (Optic Neuritis) (confirm with trial site if unsure about your specific diagnosis)

Who may not be able to join:

  • You may not be able to join if you are unable to attend all the required appointments and visits during the trial
  • You may not be able to join if you have a known HIV or Hepatitis C infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Active, Not Recruiting
Phase
Not Applicable
Sponsor
University of Texas Southwestern Medical Center
Registry
clinicaltrials_gov
Start date
1 June 2012
Est. completion
1 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measure change in standard clinical assessments over time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov